New Wearable Technology Shows Clinically Meaningful Reductions in Heavy Menstrual Bleeding
This image was generated by AI and may not depict real events.
A new wearable neurostimulation technology has shown significant reductions in heavy menstrual bleeding and related symptoms in a clinical trial. The non-invasive, drug-free treatment delivered through a wearable earpiece improved symptoms by up to 68% and reduced menstrual blood loss by up to 48%.
A clinical trial has demonstrated the effectiveness of a wearable neurostimulation technology in reducing heavy menstrual bleeding and related symptoms. The trial, which involved women with heavy menstrual bleeding, used a non-invasive, drug-free treatment delivered through a wearable earpiece. Participants experienced up to a 48% reduction in menstrual blood loss and a 68% decrease in overall menstrual symptoms. The treatment also reduced pain-related symptoms by 62% and resulted in fewer days disrupted by symptoms. The technology, called Transcutaneous Auricular Neurostimulation, delivers gentle electrical stimulation to branches of the vagus and trigeminal nerves through the ear. The study's findings suggest that this non-hormonal approach could provide a new treatment option for women suffering from heavy menstrual bleeding.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.